BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1535527)

  • 41. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral contraceptives and breast cancer.
    Schlesselman JJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1379-87. PubMed ID: 2220962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contraceptive Steroids, age, and the cardiovascular system.
    Plunkett ER
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer and oral contraceptive use.
    Rosenberg L; Miller DR; Kaufman DW; Helmrich SP; Stolley PD; Schottenfeld D; Shapiro S
    Am J Epidemiol; 1984 Feb; 119(2):167-76. PubMed ID: 6695896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptives and neoplasia.
    Huggins GR; Giuntoli RL
    Fertil Steril; 1979 Jul; 32(1):1-23. PubMed ID: 378712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitudes, regulations hinder use of the pill.
    Townsend S
    Netw Res Triangle Park N C; 1993 Mar; 13(3):6-10. PubMed ID: 12318101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on oral contraception.
    Rabe T; Runnebaum B
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):10-2. PubMed ID: 8365502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptives and breast cancer in young women.
    Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
    Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral contraceptives and risk of breast cancer.
    Paul C; Skegg DC; Spears GF
    Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.